The eyonis™ Lung Cancer Screening (LCS) REALITY data – What leading U.S. clinical pulmonology experts are saying

November 7, 2024

We invite you to join this KOL webinar featuring two globally recognized U.S. pulmonology experts to get their views on the data from REALITY and how eyonis™ LCS may impact lung cancer diagnostics and treatment practices in the real world. Panelists include Prof. Anil Vachani, from the Hospital of the University of Pennsylvania, and Prof. Javier Zulueta, from the Icahn School of Medicine at Mt Sinai. Fredrik Brag, CEO of Median Technologies, also will participate and summarize the final REALITY results, which are going to be submitted in H1 2025 to regulators for U.S. and EU marketing authorizations for eyonis™ LCS.

Register To Our Live Webcast

Get to know Median’s Imaging Lab

Transform and unlock image data from bench to bedside. With Median iCRO’s Imaging Lab, discover the true potential of leveraging Artificial Intelligence (AI), Machine Learning (ML), data mining, and radiomics in your clinical development strategy. Translate clinical trial images to insights and open new possibilities, including targeting patients with early-stage cancers.

Smart, Intuitive, Responsive

Boost your competitive advantage with rapid, valuable, and accurate image intelligence.

Unlock the power of advanced imaging data and insights to inform decisions and shape your asset development.

Select better patients

Predict response to therapy

Accurately monitor disease progression

Rapidly access safety and efficacy

See how intelligent imaging capabilities are fast becoming a necessity for driving successful clinical trials

Maintaining accuracy and consistency in image reading has its challenges. However, intelligent, innovative AI-driven technology can amplify your approach to image management, helping to accelerate time to insights and market.

Where is clinical trial imaging headed for pharma, biotech and CROs? This paper highlights how AI imaging insights and analyses add value to trial success and can help shape the future of clinical development.

DOWNLOAD THIS FREE PAPER

Identify The Most Promising Oncology Compounds Early with Proven AI-driven Clinical Trial Image Insights

Median iCRO’s Imaging Lab is an innovative life science solution that enables clinical development teams to leverage intelligent clinical trial imaging technologies to unlock answers to the most pressing bench-to-bedside challenges.

Redefine the patient journey with an AI-driven imaging approach that helps you select the right patients, detect disease relapse, identify early non-responders, and understand patients-specific molecular profiling.

Median Imaging Lab provides the insight to plan with precision, engage with personalization and optimize oncology clinical development early – helping you demonstrate product effectiveness and value in less time and more accurately across the product lifecycle.

Explore more

Median iCRO

As a global market leader in oncology clinical trial imaging, Median iCRO helps life science companies transform imaging data into life-changing insights.

Our innovative tools and techniques, and scientific and domain expertise have set a new standard in leveraging clinical trial imaging insights, improving the probability of oncology R&D success.

Learn More

iSee® Viewer

Gain expert oversight of clinical trial images with our proprietary, flexible software that helps identify, quantify, and track lesions across all time points.

Reduce human error and cover a wide range of solid tumors across cancer indications.

Learn More

iSee® Portal

Benefit from having real-time, robust clinical trial image reporting at your fingertips.

From site management, image collection, data management and reads, our reporting boosts operational performance, manages risks, and keeps you on top of your study’s imaging workflow.

Learn More

Explore what we can do for you to help improve the lives of cancer patients and their families.

Median iCRO

intelligent. insightful. innovative.

Where valuable clinical trial imaging data and analytics intersect with advancing human health.

CONTACT US
Request a proposal
Request a demo